Successful use of secukinumab in Netherton syndrome

Abstract excerpt

Netherton syndrome is an autosomal recessive disorder caused by mutations in the serine protease inhibitor Kazal type 5 gene.1 It was initially described by Comél2 and Netherton,3 and is also known as Comél-Netherton syndrome. The originally diagnostic triad described by Wilkinson et al4 consists of congenital ichthyosis, trichorrhexis invaginata, and atopic diathesis. Although variable presentations have been...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hair Growth and Disorders
• Share to Skin and Cellular Biology Research
• Share to Wnt/β-catenin signaling in development and cancer